Antibodies as pharmacologic tools for studies on the regulation of energy balance
Authors:
- Karl G. HofbauerKHKarl G. Hofbauer
- Anne-Catherine LecourtALAnne-Catherine Lecourt
- Jean-Christophe PeterJPJean-Christophe Peter
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Melanocortin‐4 Receptor Activation Stimulates Hypothalamic Brain‐Derived Neurotrophic Factor Release to Regulate Food Intake, Body Temperature and Cardiovascular FunctionJournal of Neuroendocrinology, 2007
- Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivoAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- The MC4 receptor and control of appetiteBritish Journal of Pharmacology, 2006
- Cachexia: lessons from melanocortin antagonismTrends in Endocrinology & Metabolism, 2006
- Cardiovascular responses to melanocortin 4-receptor stimulation in conscious unrestrained normotensive ratsPeptides, 2006
- Effects on heart rate of an anti‐M2 acetylcholine receptor immune response in miceThe FASEB Journal, 2005
- Anatomy and regulation of the central melanocortin systemNature Neuroscience, 2005
- The Central Melanocortin System and the Integration of Short- and Long-term Regulators of Energy HomeostasisRecent Progress in Hormone Research, 2004
- Passage of amyloid β protein antibody across the blood–brain barrier in a mouse model of Alzheimer’s diseasePeptides, 2002
- Design and Pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a Potent, Selective, Melanocortin Subtype-4 Receptor AgonistJournal of Medicinal Chemistry, 2002